HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Andreas Kjær Selected Research

Radioisotopes (Radionuclides)

10/2020Pharmacokinetic analysis of [68Ga]Ga-DOTA-TOC PET in meningiomas for assessment of in vivo somatostatin receptor subtype 2.
1/2020Noninvasive Molecular Imaging of the Enhanced Permeability and Retention Effect by 64Cu-Liposomes: In vivo Correlations with 68Ga-RGD, Fluid Pressure, Diffusivity and 18F-FDG.
1/2020Trans-Cyclooctene-Functionalized PeptoBrushes with Improved Reaction Kinetics of the Tetrazine Ligation for Pretargeted Nuclear Imaging.
1/2011Peptide receptor radionuclide therapy with Y-DOTATOC and (177)Lu-DOTATOC in advanced neuroendocrine tumors: results from a Danish cohort treated in Switzerland.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Andreas Kjær Research Topics

Disease

55Neoplasms (Cancer)
05/2024 - 11/2010
8Inflammation (Inflammations)
10/2020 - 07/2011
7Neuroendocrine Tumors (Neuroendocrine Tumor)
03/2024 - 01/2011
7Type 2 Diabetes Mellitus (MODY)
03/2022 - 03/2014
7Myocardial Infarction
01/2020 - 05/2014
6Ovarian Neoplasms (Ovarian Cancer)
05/2024 - 09/2010
6Cardiovascular Diseases (Cardiovascular Disease)
01/2021 - 07/2011
6Carcinoma (Carcinomatosis)
01/2018 - 06/2012
6Hypoxia (Hypoxemia)
01/2018 - 06/2012
5Heart Failure
01/2021 - 12/2011
5Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2020 - 01/2018
5Fibrosis (Cirrhosis)
01/2018 - 01/2014
5Coronary Artery Disease (Coronary Atherosclerosis)
01/2014 - 07/2011
4Head and Neck Neoplasms (Head and Neck Cancer)
03/2022 - 01/2016
4Squamous Cell Carcinoma of Head and Neck
01/2022 - 02/2016
4Sarcoma (Soft Tissue Sarcoma)
01/2020 - 06/2012
4Neoplasm Metastasis (Metastasis)
11/2019 - 12/2014
4Atherosclerosis
12/2016 - 08/2011
4Atherosclerotic Plaque (Atheroma)
02/2016 - 07/2015
3Breast Neoplasms (Breast Cancer)
10/2021 - 01/2018
3Carcinoid Tumor (Carcinoid)
01/2021 - 12/2014
3Infarction (Infarctions)
01/2019 - 10/2015
3Neuroendocrine Carcinoma
01/2016 - 06/2012
2Lung Neoplasms (Lung Cancer)
12/2023 - 03/2019
2Hypertrophy
03/2022 - 03/2012
2Obesity
01/2022 - 03/2014
2Cardiotoxicity
10/2020 - 01/2020
2Lymphoma (Lymphomas)
10/2020 - 01/2020
2Meningioma (Meningiomas)
10/2020 - 01/2020
2Adenocarcinoma
01/2020 - 10/2017
2Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2020 - 10/2017
2Chronic Hepatitis C
01/2019 - 01/2014
2Glioblastoma (Glioblastoma Multiforme)
10/2018 - 05/2011
2Carcinogenesis
10/2018 - 12/2014
2Insulin Resistance
01/2018 - 03/2014
2Heart Diseases (Heart Disease)
01/2018 - 08/2011
2Vascular Calcification
01/2018 - 01/2018
2HIV Infections (HIV Infection)
12/2016 - 02/2016
2Coronary Disease (Coronary Heart Disease)
02/2016 - 01/2016
2Overweight
03/2014 - 11/2013
2Colonic Neoplasms (Colon Cancer)
02/2014 - 01/2012
1Pheochromocytoma
03/2024
1Paraganglioma (Paragangliomas)
03/2024

Drug/Important Bio-Agent (IBA)

13Biomarkers (Surrogate Marker)IBA
01/2022 - 04/2013
11Liposomes (Liposome)IBA
05/2024 - 06/2012
8Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
01/2020 - 03/2012
7Glucose (Dextrose)FDA LinkGeneric
01/2022 - 01/2013
6Somatostatin Receptors (Somatostatin Receptor)IBA
03/2024 - 06/2012
5Peptides (Polypeptides)IBA
05/2024 - 11/2010
5alovudineIBA
01/2020 - 09/2010
4empagliflozinIBA
03/2022 - 11/2019
4LiraglutideFDA Link
01/2022 - 03/2014
4Glucagon-Like Peptide 1 (GLP 1)IBA
01/2021 - 03/2014
4Rubidium-82IBA
10/2020 - 01/2016
4Radioisotopes (Radionuclides)IBA
10/2020 - 01/2011
4pro-brain natriuretic peptide (1-76)IBA
03/2012 - 12/2010
3Metalloproteases (Metalloproteinases)IBA
05/2024 - 01/2014
3Peptide Receptors (Peptide Receptor)IBA
03/2024 - 01/2011
3Somatostatin (Somatotropin Release-Inhibiting Factor)IBA
03/2024 - 06/2012
3Plasminogen Activators (Plasminogen Activator)IBA
01/2022 - 05/2014
31,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA
10/2020 - 11/2010
3LigandsIBA
10/2018 - 06/2012
3Lactic Acid (Lactate)FDA LinkGeneric
01/2018 - 01/2015
3Proteins (Proteins, Gene)FDA Link
01/2018 - 12/2014
3CalciumIBA
02/2016 - 08/2011
2EnzymesIBA
05/2024 - 10/2017
2Oxaliplatin (Eloxatin)FDA LinkGeneric
05/2024 - 09/2017
2Sodium-Glucose Transport ProteinsIBA
01/2022 - 01/2021
2Urokinase Plasminogen Activator ReceptorsIBA
01/2022 - 02/2017
2AntigensIBA
10/2021 - 06/2012
2Adenosine (Adenocard)FDA LinkGeneric
10/2020 - 01/2016
2Proliferating Cell Nuclear Antigen (PCNA)IBA
10/2020 - 01/2020
2Doxorubicin (Adriamycin)FDA LinkGeneric
10/2020 - 01/2020
2CytokinesIBA
10/2020 - 10/2018
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
10/2020 - 01/2020
2NestinIBA
01/2019 - 07/2014
2MicroRNAs (MicroRNA)IBA
07/2018 - 12/2014
21- (1,3- carboxypropyl)- 4,7- carboxymethyl- 1,4,7- triazacyclononaneIBA
05/2018 - 06/2016
2Lipopolysaccharide ReceptorsIBA
01/2018 - 12/2016
2Pyruvic Acid (Pyruvate)IBA
01/2018 - 01/2015
2Phosphates (Orthophosphate)IBA
01/2018 - 01/2018
2alfacalcidolIBA
01/2018 - 01/2018
2fibrin fragment D (D-dimer)IBA
12/2016 - 02/2012
2CholesterolIBA
01/2016 - 01/2014
264Cu-DOTATATEIBA
12/2015 - 07/2015
2Atrial Natriuretic Factor (ANF)IBA
03/2014 - 01/2012
2Adrenergic Agents (Adrenergic Drugs)IBA
03/2014 - 01/2014
2DobutamineFDA LinkGeneric
03/2014 - 01/2014
1Peptide Hydrolases (Proteases)FDA Link
05/2024
1Trastuzumab (Herceptin)FDA Link
05/2024
1Matrix Metalloproteinases (MMPs)IBA
05/2024

Therapy/Procedure

21Therapeutics
10/2021 - 01/2011
11Radiotherapy
03/2024 - 07/2014
6Drug Therapy (Chemotherapy)
10/2020 - 01/2012
5Aftercare (After-Treatment)
10/2021 - 01/2012
2Neck Dissection (Radical Neck Dissection)
11/2019 - 02/2016
2Nephrectomy
01/2018 - 01/2018
2Intravenous Injections
10/2017 - 06/2012
2Art Therapy
05/2017 - 02/2016
2Carotid Endarterectomy
07/2015 - 01/2013